NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
October 31, 2006 • Volume 3 / Number 42 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Lung Cancer Screening Study Spurs Optimism, Caution

Director's Update
Help Choose the Next Roadmap Initiatives

Cancer Research Highlights
Sunitinib Benefits Patients with GIST after Imatinib Fails

Cognitive Behavior Therapy Helps Survivors Overcome Fatigue

African American Race Linked to Lower Breast Cancer Survival Rates

A Conversation with
Dr. Gary Kelloff

Spotlight
Stress Biology Yields New Opportunities

Featured Clinical Trial
Targeted Therapy for Ovarian Cancer

Notes
Gomez Honored by Avon Foundation

Niederhuber Addresses Cancer Center Directors

SPN Monograph Available

John Venditti Dies at 79

CCR Grand Rounds

Community Update
CTSU Increases Patient and Physician Access to Clinical Trials

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Featured Article

Lung Cancer Screening Study Spurs Optimism, Caution

New results from a large, observational study suggest that using spiral computed tomography (CT) to screen people at increased risk for lung cancer can detect the disease at an early stage and may increase the number of people who can be cured. Currently, the vast majority of lung cancer diagnoses aren't made until the disease is well advanced, and most of these patients die within 5 years.

Among participants in the study who received a diagnosis of lung cancer based on spiral CT screening and a resulting biopsy, 85 percent had stage I lung cancer (412 of 484), and a statistically estimated 10-year survival among these patients was 88 percent. Among stage I patients who underwent surgery within 1 month of diagnosis, the estimated 10-year survival rate was 92 percent. Very few patients in the study, however, have been followed for 10 years. Read more  



Director's Update

Help Choose the Next Roadmap Initiatives

I'd like to draw the entire cancer community's attention to a Request for Information (RFI) in the October 20 issue of NIH Guide to Grants and Contracts. This important new RFI is soliciting suggestions for new initiatives that will improve and accelerate biomedical and behavioral research and its impact on public health, to be implemented under the aegis of the NIH Roadmap for Medical Research.

The feedback generated will build the foundation from which five to eight new Roadmap initiatives will be launched, from within the currently projected Roadmap budget, beginning in Fiscal Year 2008.  Read more  


The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov